Speaking at: HRC2024

Position: Professor of Experimental Cardiology
Location: Cambridge, UK

Andrew Grace is Professor of Experimental Cardiology at the University of Cambridge. He trained in cardiology in London and Cambridge and delivered a consistently high-volume interventional practice focused on arrhythmias over >30 years. He completed post-doctoral studies as a Fulbright Scholar in San Diego returning to Cambridge as British Heart Foundation Senior Research Fellow.

He has a particular interest in disruptive’ technologies with some his work changing practice making some of the most important contributions’ to the development and implementation of subcutaneous defibrillators. He has most recently established a network based respectively in Cambridge, Seattle, Sydney and San Diego to provide physically robust models of cardiac electrical excitation extending from charge movements through structurally resolved sodium channels to surface recordings. Working with the Cavendish Laboratory and the Wellcome Trust Sanger Institute high-resolution charge density mapping is being linked to multi-omics in single cells acquired through in vivo freeze-sampling; there is high anticipation of therapeutic target identification and rescue.

He has published extensively, given many invited lectures, including hotline presentations of clinical trial data and late-breaking basic science and held Visiting Professorships internationally. He is an Editor/Editorial Board member of several journals and been a member of numerous Boards including the UK Government Commission on Human Medicines, European Medicines Agency, European Society of Cardiology Guidelines Committee and International Ambassador for the American Heart Association Leadership Committee. He is a member of Boston Scientific Inc. Safety Advisory Board and is Chair of the Scientific Advisory Board of the Heart Research Institute, Sydney.